Milestone Pharmaceuticals Inc.: Milestone Pharmaceuticals Reports Third Quarter 2024 ...
Milestone® Pharmaceuticals Inc. (Nasdaq: MIST) today reported financial results for the third quarter ended September 30, 2024 and provided ...
Milestone Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides ...
MONTREAL and CHARLOTTE, N.C., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Milestone ® Pharmaceuticals Inc. (Nasdaq: MIST) today reported financial results for the third quarter ended September 30, 2024 and ...
The FDA Is Finally Pulling a Useless Cold Medicine From the Market
Phenylephrine is both the most common decongestant on pharmacy shelves, and arguably the worst at its job. Last year, the FDA ...